{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:39:22Z","timestamp":1786991962333,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T00:00:00Z","timestamp":1685836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","celltherapyjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jcyt.2023.05.009","type":"journal-article","created":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T16:01:58Z","timestamp":1687449718000},"page":"956-966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire"],"prefix":"10.1016","volume":"25","author":[{"given":"Lindsay C.","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanna","family":"Queckb\u00f6rner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia E.","family":"Jylh\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton T\u00f6rnqvist","family":"Andr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tacha Zi Plym","family":"Forshell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina Le","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2023.05.009_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.100249","article-title":"Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis","volume":"19","author":"Thompson","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jcyt.2018.01.009","article-title":"MSCs\u08e7cells with many sides","volume":"20","author":"Le Blanc","year":"2018","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0003","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0004","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1089\/scd.2015.0120","article-title":"Different procoagulant activity of therapeutic mesenchymal stromal cells derived from bone marrow and placental decidua","volume":"24","author":"Moll","year":"2015","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.5966\/sctm.2015-0272","article-title":"Type 1 diabetes mellitus donor mesenchymal stromal cells exhibit comparable potency to healthy controls in vitro","volume":"5","author":"Davies","year":"2016","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0006","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/stem.1118","article-title":"Analysis of tissues following mesenchymal stromal cell therapy in humans indicates limited long-term engraftment and no ectopic tissue formation","volume":"30","author":"von Bahr","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0007","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/bjh.12545","article-title":"Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease","volume":"163","author":"Ball","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0008","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/db14-0656","article-title":"Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells","volume":"64","author":"Carlsson","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0009","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.stem.2009.05.003","article-title":"Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6","volume":"5","author":"Lee","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0011","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7828","article-title":"Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation","volume":"9","author":"Galleu","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0012","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1002\/stem.1386","article-title":"Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation","volume":"31","author":"Jitschin","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0013","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2012.078055","article-title":"Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6","volume":"98","author":"Melief","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0014","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/stem.2779","article-title":"Immunomodulation by therapeutic mesenchymal stromal cells (MSC) is triggered through phagocytosis of MSC by monocytic cells","volume":"36","author":"de Witte","year":"2018","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0015","doi-asserted-by":"crossref","first-page":"e60461","DOI":"10.1371\/journal.pone.0060461","article-title":"Mesenchymal stem cells engineered to inhibit complement-mediated damage","volume":"8","author":"Soland","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0016","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2012-03-420612","article-title":"Mesenchymal stem cells are injured by complement after their contact with serum","volume":"120","author":"Li","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0017","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00125-017-4316-1","article-title":"Complement C5a induces mesenchymal stem cell apoptosis during the progression of chronic diabetic complications","volume":"60","author":"Zhu","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0018","doi-asserted-by":"crossref","first-page":"12100","DOI":"10.1038\/s41598-017-12121-z","article-title":"Membrane particles generated from mesenchymal stromal cells modulate immune responses by selective targeting of pro-inflammatory monocytes","volume":"7","author":"Gon\u00e7alves F da","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0019","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1089\/scd.2013.0479","article-title":"Mesenchymal stem cells secrete immunologically active exosomes","volume":"23","author":"Zhang","year":"2014","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.0300-9475.2004.01483.x","article-title":"Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes","volume":"60","author":"Le Blanc","year":"2004","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0021","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1002\/stem.2509","article-title":"Mesenchymal stromal cell secretion of programmed death-1 ligands regulates T cell mediated immunosuppression","volume":"35","author":"Davies","year":"2017","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0022","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jcyt.2020.11.007","article-title":"Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition","volume":"23","author":"Galipeau","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0023","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/stem.2415","article-title":"Cryopreserved mesenchymal stromal cells are susceptible to T-cell mediated apoptosis which is partly rescued by IFN\u03b3 licensing","volume":"34","author":"Chinnadurai","year":"2016","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0024","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1002\/stem.1729","article-title":"Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?","volume":"32","author":"Moll","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s13287-020-02014-w","article-title":"Apoptotic bodies derived from mesenchymal stem cells promote cutaneous wound healing via regulating the functions of macrophages","volume":"11","author":"Liu","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0026","doi-asserted-by":"crossref","first-page":"e12109","DOI":"10.1002\/jev2.12109","article-title":"Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes","volume":"10","author":"Zheng","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0027","doi-asserted-by":"crossref","first-page":"e12137","DOI":"10.1002\/jev2.12137","article-title":"Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-\u03b2 upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury","volume":"10","author":"Nakazaki","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0028","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s11255-018-1844-7","article-title":"Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a\/C5aR pathway activation","volume":"50","author":"Tang","year":"2018","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0029","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30418-1","article-title":"Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial","volume":"7","author":"Matthay","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0030","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0031","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00109-012-0916-x","article-title":"Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells","volume":"90","author":"Wu","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0032","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/stem.1432","article-title":"Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages","volume":"31","author":"Melief","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0033","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1053\/j.gastro.2010.02.014","article-title":"CD206-positive M2 macrophages that express heme oxygenase-1 protect against diabetic gastroparesis in mice","volume":"138","author":"Choi","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0034","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1089\/ars.2012.4834","article-title":"CD163 and inflammation: biological, diagnostic, and therapeutic aspects","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2015.05.004","article-title":"Mesenchymal stromal cells and the innate immune response","volume":"168","author":"Le Blanc","year":"2015","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0036","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0037","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1182\/blood-2010-12-324038","article-title":"The impact of inflammatory licensing on heme oxygenase-1\u2013mediated induction of regulatory T cells by human mesenchymal stem cells","volume":"117","author":"Mougiakakos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0038","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.imbio.2006.06.002","article-title":"Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion","volume":"211","author":"Van Ginderachter","year":"2006","journal-title":"Immunobiology"},{"key":"10.1016\/j.jcyt.2023.05.009_bib0039","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.immunol.021908.132532","article-title":"Alternative activation of macrophages: an immunologic functional perspective","volume":"27","author":"Martinez","year":"2009","journal-title":"Annu Rev Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923009544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324923009544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T01:14:12Z","timestamp":1726881252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324923009544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1465324923009544"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.05.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2023.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society for Cell & Gene Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}